ReShape Lifesciences Inc [NASDAQ: RSLS] traded at a low on Wednesday, posting a -4.12 loss after which it closed the day’ session at $2.56.
The results of the trading session contributed to over 242063 shares changing hands. Over the past one week, the price volatility of ReShape Lifesciences Inc stands at 13.99% while the volatility over the past one month is 19.72%.
The market cap for RSLS stock reached $6.11 million, with 2.39 million shares outstanding and 2.39 million shares in the current float. Compared to the average trading volume of 2.95M shares, RSLS reached a trading volume of 242063 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about ReShape Lifesciences Inc [RSLS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RSLS shares is $1450.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RSLS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for ReShape Lifesciences Inc is set at 1.13, with the Price to Sales ratio for RSLS stock in the period of the last 12 months amounting to 0.85. The Price to Book ratio for the last quarter was 0.28, with the Price to Cash per share for the same quarter was set at 1.10.
How has RSLS stock performed recently?
ReShape Lifesciences Inc [RSLS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.79. With this latest performance, RSLS shares dropped by -60.43% in over the last four-week period, additionally sinking by -97.83% over the last 6 months – not to mention a drop of -99.10% in the past year of trading.
ReShape Lifesciences Inc [RSLS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and ReShape Lifesciences Inc [RSLS] shares currently have an operating margin of -87.75% and a Gross Margin at 63.74%. ReShape Lifesciences Inc’s Net Margin is presently recorded at -48.26%.
Return on Equity for this stock declined to -47.07%, with Return on Assets sitting at -47.07%.
Insider trade positions for ReShape Lifesciences Inc [RSLS]
There are presently around $0.73%, or 0.81%% of RSLS stock, in the hands of institutional investors.
